Literature DB >> 28328547

Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.

Andrew J Levine1, Eileen Martin, Ned Sacktor, Cynthia Munro, James Becker.   

Abstract

BACKGROUND: Prevalence estimates of HIV-associated neurocognitive disorders (HAND) may be inflated. Estimates are determined via cohort studies in which participants may apply suboptimal effort on neurocognitive testing, thereby inflating estimates. Additionally, fluctuating HAND severity over time may be related to inconsistent effort. To address these hypotheses, we characterized effort in the Multicenter AIDS Cohort Study.
METHODS: After neurocognitive testing, 935 participants (525 HIV- and 410 HIV+) completed the visual analog effort scale (VAES), rating their effort from 0% to 100%. Those with <100% then indicated the reason(s) for suboptimal effort. K-means cluster analysis established 3 groups: high (mean = 97%), moderate (79%), and low effort (51%). Rates of HAND and other characteristics were compared between the groups. Linear regression examined the predictors of VAES score. Data from 57 participants who completed the VAES at 2 visits were analyzed to characterize the longitudinal relationship between effort and HAND severity.
RESULTS: Fifty-two percent of participants reported suboptimal effort (<100%), with no difference between serostatus groups. Common reasons included "tired" (43%) and "distracted" (36%). The lowest effort group had greater asymptomatic neurocognitive impairment and minor neurocognitive disorder diagnosis (25% and 33%) as compared with the moderate (23% and 15%) and the high (12% and 9%) effort groups. Predictors of suboptimal effort were self-reported memory impairment, African American race, and cocaine use. Change in effort between baseline and follow-up correlated with change in HAND severity.
CONCLUSIONS: Suboptimal effort seems to inflate estimated HAND prevalence and explain fluctuation of severity over time. A simple modification of study protocols to optimize effort is indicated by the results.

Entities:  

Mesh:

Year:  2017        PMID: 28328547      PMCID: PMC5429190          DOI: 10.1097/QAI.0000000000001371

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  46 in total

1.  A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise.

Authors:  S Grant; T Aitchison; E Henderson; J Christie; S Zare; J McMurray; H Dargie
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

2.  I just want my research credit: frequency of suboptimal effort in a non-clinical healthy undergraduate sample.

Authors:  Jonathan DeRight; Randall S Jorgensen
Journal:  Clin Neuropsychol       Date:  2014-12-10       Impact factor: 3.535

3.  Motivated to do well: an examination of the relationships between motivation, effort, and cognitive performance in schizophrenia.

Authors:  G Foussias; I Siddiqui; G Fervaha; S Mann; K McDonald; O Agid; K K Zakzanis; G Remington
Journal:  Schizophr Res       Date:  2015-05-23       Impact factor: 4.939

4.  Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.

Authors:  Erin E Morgan; Steven Paul Woods; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2012-02-15       Impact factor: 2.813

5.  The prevalence of cognitive malingering in persons reporting exposure to occupational and environmental substances.

Authors:  Kevin W Greve; Kevin J Bianchini; F William Black; Matthew T Heinly; Jeffrey M Love; Douglas A Swift; Megan Ciota
Journal:  Neurotoxicology       Date:  2006-07-06       Impact factor: 4.294

6.  Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Authors:  Valerio Tozzi; Pietro Balestra; Rita Bellagamba; Angela Corpolongo; Maria Flora Salvatori; Ubaldo Visco-Comandini; Chrysoula Vlassi; Marinella Giulianelli; Simonetta Galgani; Andrea Antinori; Pasquale Narciso
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

7.  Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

Authors:  Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

8.  Prevalence of cognitive disorders differs as a function of age in HIV virus infection.

Authors:  James T Becker; Oscar L Lopez; Mary Amanda Dew; Howard J Aizenstein
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  Cognitive disorders in HIV-infected patients: are they HIV-related?

Authors:  Fabrice Bonnet; Hélène Amieva; Fabienne Marquant; Charlotte Bernard; Mathias Bruyand; Frédéric-Antoine Dauchy; Patrick Mercié; Carine Greib; Laura Richert; Didier Neau; Gwenaelle Catheline; Patrick Dehail; Francois Dabis; Philippe Morlat; Jean-François Dartigues; Geneviève Chêne
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

10.  Examining the range of normal intraindividual variability in neuropsychological test performance.

Authors:  David J Schretlen; Cynthia A Munro; James C Anthony; Godfrey D Pearlson
Journal:  J Int Neuropsychol Soc       Date:  2003-09       Impact factor: 2.892

View more
  2 in total

1.  Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.

Authors:  Robert Paul; Gina Rhee; Laurie M Baker; Florin Vaida; Sarah A Cooley; Beau M Ances
Journal:  J Neurovirol       Date:  2017-09-11       Impact factor: 2.643

2.  No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV.

Authors:  Austin Quach; Steve Horvath; Natasha Nemanim; Dimitrios Vatakis; Mallory D Witt; Eric N Miller; Roger Detels; Peter Langfelder; Paul Shapshak; Elyse J Singer; Andrew J Levine
Journal:  J Neurovirol       Date:  2018-03-26       Impact factor: 2.643

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.